Kevin Doe created a new article
3 yrs

The biopharmaceutical contract biomanufacturing market is projected to be worth USD 32.4 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis | #biopharmaceutical contract # Roots Analysis # Market # Pharma

The biopharmaceutical contract biomanufacturing market is projected to be worth USD 32.4 billion by 2030, growing at a C

The biopharmaceutical contract biomanufacturing market is projected to be worth USD 32.4 billion by 2030, growing at a C

Owing to the complexities associated with the production of biologics, biopharmaceutical developers are likely to continue relying on contract service providers